BCHE and Alzheimer disease: Consequently, the starting point for the treatment of AD is the inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), both responsible for the hydrolysis of ACh in the cholinergic synapse [12,13,14,15,16,17].